alprazolam has been researched along with fluoxetine in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (13.95) | 18.7374 |
1990's | 14 (32.56) | 18.2507 |
2000's | 11 (25.58) | 29.6817 |
2010's | 11 (25.58) | 24.3611 |
2020's | 1 (2.33) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cotreau, MM; Greenblatt, DJ; Harmatz, JS; Horst, WD; Preskorn, SH | 1 |
Botsis, AJ; Brown, SL; Chen, C; Grosz, D; Korn, ML; Kotler, M; Molcho, A; Plutchik, R; van Praag, HM | 1 |
Antal, EJ; Fleishaker, JC; Lasher, TA; Steenwyk, RC | 1 |
Sholomskas, AJ | 1 |
Halaris, A; Saran, A | 1 |
Decaria, C; Fairbanks, J; Hollander, E; Liebowitz, MR | 1 |
Ostrow, D | 1 |
Brown, TM; Evans, DL; Golden, RN; Miller, H | 1 |
Cohen, BS; Dillon, D; Fyer, AJ; Gorman, JM; Klein, DF; Liebowitz, MR | 1 |
Feighner, JP | 1 |
van Leusden, HA | 1 |
Campbell, M; Cueva, JE | 1 |
Alain, J; Brosset, A; Nouaille, Y; Tabaste, JL; Vendittelli, F | 1 |
Andriushchenko, AV; Koliutskaia, EV; Morkovkina, IV; Smulevich, AB; Tkhostov, ASh | 1 |
Amsterdam, JD; Hornig-Rohan, M; Maislin, G | 1 |
Hammerness, PG; Kaspi, SP; Otto, MW; Pollack, MH; Rosenbaum, JF | 1 |
Coplan, JD; Gorman, JM; Papp, LA; Tiffon, L | 1 |
Banfi, R; Borselli, G; Pazzagli, L; Semmola, MV | 1 |
Matthews, J; Pollack, MH; Scott, EL | 1 |
da Fonseca, AM; Diegoli, CA; Diegoli, MS; Pinotti, JA | 1 |
Leander, JD; Wolff, MC | 1 |
Krsiak, M; Moravec, V; Votava, M | 1 |
Hall, J; Herrmann, N; Naranjo, CA; Sproule, BA | 1 |
Boerner, RJ | 1 |
Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L | 1 |
Seibert, LM | 1 |
Hogg, S; Jessa, M; Michan, L | 1 |
Beyer, CE; Dwyer, JM; Leonard, SK; Logue, SF; Malberg, JE; Neal, SJ; Platt, B; Ring, RH; Rosenzweig-Lipson, S; Schechter, LE; Sukoff Rizzo, SJ | 1 |
Amaral, VC; Campos, KF; Miguel, TT; Nunes-de-Souza, RL; Rico, JL | 1 |
Mendes-Gomes, J; Nunes-de-Souza, RL; Rico, JL; Rodgers, RJ; Sorregotti, T | 1 |
Bain, MJ; Stepita, ME | 1 |
Eren Cevik, S; Guneysel, O; Tasyurek, T | 1 |
Asoodeh, A; Dangkoob, F; Housaindokht, MR; Rajabi, O; Rouhbakhsh Zaeri, Z; Verdian Doghaei, A | 1 |
Dierksen, J; Gonsoulin, M; Walterscheid, JP | 1 |
Holman, HJ | 1 |
Orlando, JM | 1 |
Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A | 1 |
6 review(s) available for alprazolam and fluoxetine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The new antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Fluoxetine; Maprotiline; Nomifensine; Seizures; Trazodone | 1988 |
The new generation of antidepressants.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Zimeldine | 1983 |
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Clonidine; Clozapine; Depressive Disorder; Dose-Response Relationship, Drug; Feeding and Eating Disorders; Fluoxetine; Humans; Imipramine; Lithium; Mutism; Obsessive-Compulsive Disorder; Phenobarbital; Phenytoin; Phobic Disorders; Schizophrenia; Sleep Wake Disorders; Tranquilizing Agents | 1995 |
[Panic attacks and panic disorder. Checklist for the diagnosis].
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Behavior Therapy; Depression; Diagnosis, Differential; Emergencies; Female; Fluoxetine; Humans; Male; Myocardial Infarction; Panic Disorder; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Time Factors | 2003 |
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2023 |
9 trial(s) available for alprazolam and fluoxetine
Article | Year |
---|---|
Fluoxetine impairs clearance of alprazolam but not of clonazepam.
Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Clonazepam; Double-Blind Method; Drug Interactions; Fluoxetine; Half-Life; Humans; Male; Reference Values | 1992 |
Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.
Topics: Adult; Affect; Alprazolam; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Interactions; Fluoxetine; Humans; Male; Psychomotor Performance; Spectrophotometry, Ultraviolet | 1991 |
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
The new generation of antidepressants.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Zimeldine | 1983 |
[The psychopharmacotherapy of anxious-depressive states (the interrelationship of the structure of the comorbidity to the choice of drug therapy)].
Topics: Adult; Alprazolam; Anxiety; Comorbidity; Depression; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Phobic Disorders; Psychopathology; Psychotropic Drugs; Statistics, Nonparametric | 1994 |
Cognitive behavior therapy for treatment-refractory panic disorder.
Topics: Adult; Alprazolam; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Pilot Projects; Psychiatric Status Rating Scales; Psychotherapy, Group; Treatment Outcome | 1994 |
A double-blind trial of four medications to treat severe premenstrual syndrome.
Topics: Alprazolam; Anti-Anxiety Agents; Double-Blind Method; Female; Fluoxetine; Humans; Premenstrual Syndrome; Pyridoxine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1998 |
Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Area Under Curve; Citalopram; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Drug Interactions; Fluoxetine; Half-Life; Humans | 2003 |
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride | 2004 |
29 other study(ies) available for alprazolam and fluoxetine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Suicide and violence associated with panic attacks.
Topics: Adult; Alprazolam; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Rage; Suicide; Suicide Prevention; Violence | 1992 |
Mania in a panic disorder patient treated with fluoxetine.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Fear; Fluoxetine; Humans; Male; Panic | 1990 |
Panic attack precipitated by fluoxetine.
Topics: Adult; Alprazolam; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Panic Disorder; Psychiatric Status Rating Scales; Trazodone | 1989 |
Pharmacological dissection of panic and depersonalization.
Topics: Adolescent; Alprazolam; Anxiety Disorders; Depersonalization; Fear; Female; Fluoxetine; Humans; Imipramine; Manuals as Topic; Panic | 1989 |
Antipanic drug effects during lactate infusion in lactate-refractory panic patients.
Topics: Adult; Agoraphobia; Alprazolam; Clonidine; Desipramine; Fear; Female; Fluoxetine; Humans; Imipramine; Lactates; Lactic Acid; Male; Panic; Phobic Disorders; Psychological Tests; Psychotropic Drugs | 1987 |
Premenstrual syndrome no progesterone; premenstrual dysphoric disorder no serotonin deficiency.
Topics: Affect; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Premenstrual Syndrome; Progesterone; Selective Serotonin Reuptake Inhibitors; Serotonin | 1995 |
A case of lipomeningocele reported with fluoxetine (and alprazolam, vitamins B1 and B6, heptaminol) prescribed during pregnancy.
Topics: Adult; Alprazolam; Depression; Drug Therapy, Combination; Female; Fluoxetine; Heptaminol; Humans; Infant, Newborn; Lipoma; Meningocele; Pregnancy; Pregnancy Complications; Pyridoxine; Spinal Dysraphism; Thiamine | 1995 |
Efficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depression.
Topics: Adult; Akathisia, Drug-Induced; Alprazolam; Ambulatory Care; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Prospective Studies; Severity of Illness Index | 1994 |
Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients.
Topics: Adult; Alprazolam; Antidepressive Agents, Tricyclic; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Imipramine; Lorazepam; Male; Panic Disorder; Retrospective Studies; Treatment Outcome | 1994 |
Photosensitivity reaction to fluoxetine and alprazolam.
Topics: Adult; Alprazolam; Antidepressive Agents, Second-Generation; Depression; Ethiopia; Fluoxetine; Humans; Male; Photosensitivity Disorders | 1998 |
Gabapentin as a potential treatment for anxiety disorders.
Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids; Diazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Panic Disorder; Phobic Disorders | 1998 |
Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alprazolam; Analysis of Variance; Animals; Anti-Anxiety Agents; Chlordiazepoxide; Columbidae; Cyclohexanes; Dose-Response Relationship, Drug; Fluoxetine; Impulsive Behavior; Male; Piperazines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reinforcement Schedule; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Time Factors | 2002 |
Effects of alprazolam and fluoxetine on morphine sensitization in mice.
Topics: Alprazolam; Animals; Fluoxetine; Male; Mice; Mice, Inbred ICR; Morphine; Motor Activity; Narcotic Antagonists; Narcotics | 2002 |
Animal behavior case of the month. Urine spraying and inappropriate urination for the past 10 years.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Behavior Therapy; Cat Diseases; Cats; Eliminative Behavior, Animal; Fluoxetine; Male; Treatment Outcome; Urination Disorders | 2004 |
Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anxiety; Citalopram; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Hypnotics and Sedatives; Male; Motor Activity; Panic Disorder; Paroxetine; Periaqueductal Gray; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques; Yohimbine | 2006 |
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Arousal; Body Temperature Regulation; Calcium; Cell Line; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fear; Fluoxetine; Humans; In Vitro Techniques; Male; Maze Learning; Mice; Motor Activity; Neuropeptides; Oxytocin; Peptide Fragments; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2008 |
Ethopharmacological evaluation of the rat exposure test: a prey-predator interaction test.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Caffeine; Central Nervous System Stimulants; Diazepam; Escape Reaction; Factor Analysis, Statistical; Fluoxetine; Food Chain; Imipramine; Male; Mice; Motor Activity; Posture; Predatory Behavior; Rats; Rats, Long-Evans; Time Factors; Yohimbine | 2013 |
Ethopharmacological analysis of the open elevated plus-maze in mice.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Convulsants; Corticosterone; Diazepam; Factor Analysis, Statistical; Fluoxetine; Male; Maze Learning; Mice; Pentylenetetrazole; Statistics, Nonparametric; Yohimbine | 2013 |
Animal behavior case of the month. Noise phobia, cognitive dysfunction, separation anxiety, attention-seeking behavior, and medical causes.
Topics: Aggression; Alprazolam; Animals; Behavior, Animal; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Fluoxetine; Hypnotics and Sedatives; Noise; Phobic Disorders; Selective Serotonin Reuptake Inhibitors | 2013 |
Intralipid emulsion treatment as an antidote in lipophilic drug intoxications.
Topics: Adolescent; Adult; Alprazolam; Amitriptyline; Antidotes; Blood Pressure; Dibenzothiazepines; Drug Overdose; Fat Emulsions, Intravenous; Female; Fluoxetine; Glasgow Coma Scale; Heart Rate; Humans; Lamotrigine; Lipid Metabolism; Male; Metoprolol; Middle Aged; Nifedipine; Quetiapine Fumarate; Triazines; Young Adult | 2014 |
Spectroscopic and molecular modeling study on the separate and simultaneous bindings of alprazolam and fluoxetine hydrochloride to human serum albumin (HSA): with the aim of the drug interactions probing.
Topics: Alprazolam; Fluoxetine; Humans; Models, Chemical; Models, Molecular; Protein Binding; Serum Albumin; Spectrophotometry, Ultraviolet | 2015 |
Poor Man's Methadone: A Case Report of Loperamide Toxicity.
Topics: Alprazolam; Antidiarrheals; Chromatography, Liquid; Fluoxetine; Humans; Hypertrophy; Loperamide; Male; Mass Spectrometry; Substance-Related Disorders; Urinary Bladder; Young Adult | 2015 |
COMBINATION THERAPY WITH FLUOXETINE AND ALPRAZOLAM TO CONTROL ANXIETY IN A HAND-REARED SNOW LEOPARD (UNCIA UNCIA).
Topics: Adrenergic Uptake Inhibitors; Alprazolam; Animals; Animals, Zoo; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Drug Therapy, Combination; Felidae; Fluoxetine; Male | 2016 |
Animal Behavior Case of the Month.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Diazepam; Dog Diseases; Dogs; Fear; Fluoxetine; Gabapentin; Male; Noise; Paroxetine; Phobic Disorders | 2017 |